A phase 1/2, randomized, placebo controlled and open label...

A phase 1/2, randomized, placebo controlled and open label extension studies of Givosiran and investigational RNA interference therapeutic, in patients with acute intermittent porphyria

Sardh, E., Balwani, M., Harper, P., Stein, P., Rees, D., Bloomer, J., Bissell, D.M., Parket, C., Phillips, J., Bonkovsky, H., Desnick, R., Al-Tawil, N., Rock, S., Penz, C., Chan, A., Querbes, W., Simo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(18)30354-4
Date:
April, 2018
File:
PDF, 61 KB
english, 2018
Conversion to is in progress
Conversion to is failed